Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 231–231 | Cite as

Osimertinib

Drug resistance: 29 case reports
Case report
  • 15 Downloads

Reference

  1. Le X, et al. Landscape of EGFR-dependent and -independent resistance mechanisms to osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC. Clinical Cancer Research 24: 6195-6203, No. 24, Dec 2018. Available from: URL: http://doi.org/10.1158/1078-0432.CCR-18-1542 - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations